Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, October 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 129 articles:
HTML format


 

Single Articles

  1. GROEGER D, Murphy EF, Tan HTT, Larsen IS, et al
    Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.
    Neurogastroenterol Motil. 2022 Sep 30:e14477. doi: 10.1111/nmo.14477.
    PubMed    
    Abstract available

  2. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Willingness to pay for medications among patients with Rome IV irritable Bowel syndrome.
    Neurogastroenterol Motil. 2022 Sep 30:e14483. doi: 10.1111/nmo.14483.
    PubMed    
    Abstract available

  3. KIM N, Kim J, Yang BR, Hahm BJ, et al
    Associations of unspecified pain, idiopathic pain and COVID-19 in South Korea: a nationwide cohort study.
    Korean J Pain. 2022;35:458-467.
    PubMed    
    Abstract available

  4. BYALE A, Lennon RJ, Byale S, Breen-Lyles M, et al
    High-dimensional clustering of 4000 Irritable Bowel Syndrome Patients reveals Seven Distinct Disease Subsets.
    Clin Gastroenterol Hepatol. 2022 Sep 26. pii: S1542-3565(22)00917.
    PubMed    
    Abstract available

  5. ARAI T, Inoue Y
    Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  6. MENG Y, Feng Y, Hang L, Zhou Y, et al
    No synergistic effect of fecal microbiota transplantation and shugan decoction in water avoidance stress-induced IBS-D rat model.
    Front Microbiol. 2022;13:995567.
    PubMed    
    Abstract available

  7. HOJO M, Nagahara A
    Current perspectives on irritable bowel syndrome: a narrative review.
    J Int Med Res. 2022;50:3000605221126370.
    PubMed    
    Abstract available

  8. WU J, Wang C, Lv L
    Diagnostic yield of colonoscopy for organic disease in irritable bowel syndrome and its risk factors: A meta-analysis.
    Neurogastroenterol Motil. 2022 Sep 27:e14481. doi: 10.1111/nmo.14481.
    PubMed    
    Abstract available

  9. BRIERLEY SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, et al
    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2022 Sep 27. pii: 10.1038/s41575-022-00682.
    PubMed    
    Abstract available

  10. LI HY, Chen Y, Hu ZY, Chen W, et al
    [Meta analysis of acupuncture and moxibustion for anxiety and depression in irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2022;47:821-9.
    PubMed    
    Abstract available

  11. COSTANTINO A, Pessarelli T, Vecchiato M, Vecchi M, et al
    A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome.
    Dig Liver Dis. 2022 Sep 21. pii: S1590-8658(22)00663.
    PubMed    


  12. DEMIRBAS A, Elmas OF, Eker H, Demirbas GU, et al
    The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study.
    Turk J Med Sci. 2022;52:97-104.
    PubMed    
    Abstract available

  13. DONG X, Yang Y, Luo S, Deng X, et al
    Upregulation of P2X3 receptors in primary afferent pathways involves in colon-to-bladder cross-sensitization in rats.
    Front Physiol. 2022;13:920044.
    PubMed    
    Abstract available

  14. WU PN, Xiong S, Zhong P, Yang WQ, et al
    Global trends in research on irritable bowel syndrome and the brain-gut axis: Bibliometrics and visualization analysis.
    Front Pharmacol. 2022;13:956204.
    PubMed    
    Abstract available

  15. IKEDA Y, Taniguchi K, Sawamura H, Tsuji A, et al
    Promising role of D-amino acids in irritable bowel syndrome.
    World J Gastroenterol. 2022;28:4471-4474.
    PubMed    
    Abstract available

  16. NISHIDA A, Nishino K, Ohno M, Sakai K, et al
    Update on gut microbiota in gastrointestinal diseases.
    World J Clin Cases. 2022;10:7653-7664.
    PubMed    
    Abstract available

  17. JIANG S, Song CY, Feng MX, Lu YQ, et al
    Adult patients with allied disorders of Hirschsprung's disease in emergency department: An 11-year retrospective study.
    World J Gastrointest Surg. 2022;14:656-669.
    PubMed    
    Abstract available

  18. MALLARET G, Lashermes A, Meleine M, Boudieu L, et al
    Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation.
    World J Gastroenterol. 2022;28:3903-3916.
    PubMed    
    Abstract available

  19. QUAGLIO AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, et al
    Gut microbiota, inflammatory bowel disease and colorectal cancer.
    World J Gastroenterol. 2022;28:4053-4060.
    PubMed    
    Abstract available

  20. FANG XC, Fan WJ, Drossman DD, Han SM, et al
    Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    World J Gastroenterol. 2022;28:4861-4874.
    PubMed    
    Abstract available

  21. POMENTI S, Devinsky J, Jodorkovsky D
    Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction.
    Med Clin North Am. 2022;106:899-912.
    PubMed    
    Abstract available

  22. M H S, P E H, C F, S B, et al
    Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety.
    Neurogastroenterol Motil. 2022 Sep 25:e14465. doi: 10.1111/nmo.14465.
    PubMed    
    Abstract available

  23. BARBA E, Burri E, Quiroga S, Accarino A, et al
    Visible abdominal distension in functional gut disorders: Objective evaluation.
    Neurogastroenterol Motil. 2022 Sep 25:e14466. doi: 10.1111/nmo.14466.
    PubMed    
    Abstract available

  24. MURATORE A, Shah ED, Chan WW
    Cost-Benefit Analysis of Hydrogen Breath Test-Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2022 Sep 21. pii: S1542-3565(22)00907.
    PubMed    


  25. SVENSSON A, Roth B, Kronvall L, Ohlsson B, et al
    TSH receptor antibodies (TRAb) - A potential new biomarker for endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:115-121.
    PubMed    
    Abstract available

  26. WENDT L, Brandt J, Ushakov DS, Bodmer BS, et al
    Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.
    J Virol. 2022;96:e0090022.
    PubMed    
    Abstract available

  27. RAY K
    Bacterial histamine and abdominal pain in IBS.
    Nat Rev Gastroenterol Hepatol. 2022;19:623.
    PubMed    


  28. NARAYANA V, McMeans AR, Levy RL, Shulman RJ, et al
    Children with functional abdominal pain disorders successfully decrease FODMAP food intake on a low FODMAP diet with modest improvements in nutritional intake and diet quality.
    Neurogastroenterol Motil. 2022;34:e14392.
    PubMed    
    Abstract available

  29. GOLLIFER RM, Taylor SA, Menys A, Zarate-Lopez N, et al
    Magnetic resonance imaging assessed enteric motility and luminal content analysis in patients with severe bloating and visible distension.
    Neurogastroenterol Motil. 2022;34:e14381.
    PubMed    
    Abstract available

  30. ATAY O, David J, Mehta A
    A Hypothetical Case Example Illustrating the Importance of a Multidisciplinary Approach to Treating Chronic/Functional Abdominal Pain in Pediatric Patients.
    Pediatr Clin North Am. 2022;69:917-927.
    PubMed    
    Abstract available

  31. OKAFOR PN, Dahlen A, Youssef M, Olayode A, et al
    Environmental Pollutants are Associated with Irritable Bowel Syndrome in a Commercially Insured Cohort of California Residents.
    Clin Gastroenterol Hepatol. 2022 Sep 30. pii: S1542-3565(22)00923.
    PubMed    
    Abstract available

  32. WANG Y, Cui W, Yang C, Wei H, et al
    Comparison of Geqingpi and Sihuaqingpi based on ultra high performance liquid chromatography-tandem mass spectrometry combined with multivariate statistics, network pharmacology analysis, and molecular docking.
    J Sep Sci. 2022 Oct 6. doi: 10.1002/jssc.202200564.
    PubMed    
    Abstract available

  33. HABIB N, Buzzaccarini G, Centini G, Moawad GN, et al
    Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner.
    Prz Menopauzalny. 2022;21:124-132.
    PubMed    
    Abstract available

  34. BOURSEAU S, Bastens B, Leclercq P
    Umbilical spider's web.
    Acta Gastroenterol Belg. 2022;85:542.
    PubMed    
    Abstract available

  35. NOVLJAN U, Pintar T
    Small Intestinal Bacterial Overgrowth in Patients with Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass.
    Obes Surg. 2022 Oct 5. pii: 10.1007/s11695-022-06299.
    PubMed    
    Abstract available

  36. WANG F, Zhao T, Wang W, Dai Q, et al
    Meta-analysis of the efficacy of probiotics to treat diarrhea.
    Medicine (Baltimore). 2022;101:e30880.
    PubMed    
    Abstract available

  37. ZHANG M, Zheng Y, Li X, Wu H, et al
    Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2alpha-ATF4 signaling pathway.
    Phytomedicine. 2022;107:154350.
    PubMed    
    Abstract available

  38. YUAN Y, Wu H, Pan H
    Comparative analysis of the fecal microbiome and metabolomics of healthy versus captive South China tigers with mild-diarrhea.
    Can J Microbiol. 2022 Oct 4. doi: 10.1139/cjm-2022-0115.
    PubMed    
    Abstract available

  39. HUANG HL, Zhu JQ, Yang LS, Wu Q, et al
    Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
    Oxid Med Cell Longev. 2022;2022:5121496.
    PubMed    
    Abstract available

  40. SHARAWI S, Graffeo V, Goebel LJ
    Sclerosing Mesenteritis: A Rare Cause of Abdominal Pain.
    Cureus. 2022;14:e28573.
    PubMed    
    Abstract available

  41. SATO T, Honda S, Tominaga Y, Miyakoshi Y, et al
    A probiotic blend improves defecation, mental health, and productivity in healthy Japanese volunteers under stressful situations.
    Heliyon. 2022;8:e10614.
    PubMed    
    Abstract available

  42. LARAUCHE M, Erchegyi J, Miller C, Sim MS, et al
    Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.
    Peptides. 2022;157:170881.
    PubMed    
    Abstract available

  43. YI SL, Huang ZT, Liao L, Lu YL, et al
    The Effects of Patchouli Alcohol on Diarrhea-Predominant Irritable Bowel Syndrome are Correlated with Phenotypic Plasticity in Myenteric Neurons and the Targeted Regulation of Myosin Va.
    Am J Chin Med. 2022 Oct 3:1-21. doi: 10.1142/S0192415X22500811.
    PubMed    
    Abstract available

  44. RAJ SR, Sheldon RS
    Vasovagal syncope: Treat the patient, and not just the disease.
    Auton Neurosci. 2022;243:103035.
    PubMed    


  45. LOH-DOYLE JC, Stephens-Shields AJ, Rolston R, Newcomb C, et al
    Predictors of Male Sexual Dysfunction in Urologic Chronic Pelvic Pain Syndrome (UCPPS), Other Chronic Pain Syndromes, and Healthy Controls in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
    J Sex Med. 2022 Sep 27. pii: S1743-6095(22)01774.
    PubMed    
    Abstract available

  46. LIU P, Zhang S, Ma J, Jin D, et al
    Vimentin inhibits alpha-tubulin acetylation via enhancing alpha-TAT1 degradation to suppress the replication of human parainfluenza virus type 3.
    PLoS Pathog. 2022;18:e1010856.
    PubMed    
    Abstract available

  47. CHENG X, Guo B, Hu Y
    Distinct neural couplings to shared goal and action coordination in joint action: evidence based on fNIRS hyperscanning.
    Soc Cogn Affect Neurosci. 2022;17:956-964.
    PubMed    
    Abstract available

  48. JIN S, Lu X, Xu C
    COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
    J Int Med Res. 2022;50:3000605221129543.
    PubMed    
    Abstract available

  49. RICCI C, Rizzello F, Valerii MC, Spisni E, et al
    Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  50. ABBOUD M, Haidar S, Mahboub N, Papandreou D, et al
    Association between Serum Vitamin D and Irritable Bowel Syndrome Symptoms in a Sample of Adults.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  51. BAYER SB, Heenan P, Frampton C, Wall CL, et al
    Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults-A Randomized Clinical Trial.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  52. AUPETIT A, Grigioni S, Roman H, Coeffier M, et al
    Association between Endometriosis, Irritable Bowel Syndrome and Eating Disorders: ENDONUT Pilot Study.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  53. WASEEM MR, Shin A, Siwiec R, James-Stevenson T, et al
    ASSOCIATIONS OF FECAL SHORT CHAIN FATTY ACID WITH COLONIC TRANSIT, FECAL BILE ACIDS, AND FOOD INTAKE IN IRRITABLE BOWEL SYNDROME.
    Clin Transl Gastroenterol. 2022 Oct 13. pii: 01720094-990000000-00102.
    PubMed    
    Abstract available

  54. PATEL SJ, Kaye A, Meyers SR, Ahlawat S, et al
    Outcomes of Patients Who Developed Clostridioides difficile Infection During Hospitalization and Had a History of Comorbid Post-Traumatic Stress Disorder.
    Cureus. 2022;14:e28810.
    PubMed    
    Abstract available

  55. TIAN YQ, Zhang SP, Zhang KL, Cao D, et al
    Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway.
    Evid Based Complement Alternat Med. 2022;2022:6010858.
    PubMed    
    Abstract available

  56. ZIA S, Saleem M, Asif M, Hussain K, et al
    Diospyros malabarica (Desr.) Kostel fruits extract attenuated acute and chronic inflammation through modulation of the expression of pro- and anti-inflammatory biomarkers in rat models.
    Inflammopharmacology. 2022 Oct 12. pii: 10.1007/s10787-022-01048.
    PubMed    
    Abstract available

  57. ALGERA JP, Colomier E, Melchior C, Hreinsson JP, et al
    Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome.
    Neurogastroenterol Motil. 2022 Oct 11:e14482. doi: 10.1111/nmo.14482.
    PubMed    
    Abstract available

  58. LACY BE, Cangemi DJ
    Updates in functional dyspepsia and bloating.
    Curr Opin Gastroenterol. 2022;38:613-619.
    PubMed    
    Abstract available

  59. SUGIYAMA Y, Mori Y, Nara M, Kotani Y, et al
    Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production.
    Gut Microbes. 2022;14:2128605.
    PubMed    
    Abstract available

  60. GIRON MC, Baj A, Giaroni C
    Editorial: Neuroendocrine signalling pathways along the microbiota-gut-brain axis in functional gut disorders.
    Front Endocrinol (Lausanne). 2022;13:996382.
    PubMed    


  61. LI H, Zhang W, Ma F, Zhang X, et al
    Abdominal Massage Improves the Symptoms of Irritable Bowel Syndrome by Regulating Mast Cells via the Trypase-PAR2-PKCepsilon Pathway in Rats.
    Pain Res Manag. 2022;2022:8331439.
    PubMed    
    Abstract available

  62. BHATTACHARJEE G, Khambhati K, Gohil N, Singh P, et al
    Gut microbiota in gastrointestinal diseases.
    Prog Mol Biol Transl Sci. 2022;191:141-151.
    PubMed    
    Abstract available

  63. GARVEY SM, Mah E, Blonquist TM, Kaden VN, et al
    The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial in healthy adults.
    Gut Microbes. 2022;14:2122668.
    PubMed    
    Abstract available

  64. CAREY ET, Geller EJ, Rapkin A, Farb D, et al
    Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe).
    Ann Med. 2022;54:2885-2897.
    PubMed    
    Abstract available

  65. OMES C, Tomasoni V, De Amici M, Testa G, et al
    Calprotectin as a novel diagnostic approach to screen male infertility risk: A pilot study.
    Immunobiology. 2022;227:152291.
    PubMed    
    Abstract available

  66. FAN W, Fang X, Hu C, Fei G, et al
    Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt proteome microarray.
    Front Physiol. 2022;13:1010069.
    PubMed    
    Abstract available

  67. LALOUNI M, Bujacz A, Bonnert M, Jensen KB, et al
    Parental responses and catastrophizing in online cognitive behavioral therapy for pediatric functional abdominal pain: A mediation analysis of a randomized controlled trial.
    Front Pain Res (Lausanne). 2022;3:962037.
    PubMed    
    Abstract available

  68. CHEN KH, Zeng BY, Zeng BS, Sun CK, et al
    The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials.
    J Formos Med Assoc. 2022 Oct 15. pii: S0929-6646(22)00385.
    PubMed    
    Abstract available

  69. CHEN Z, Liu Y, Wu X, Lin W, et al
    Spinal circKcnk9 regulates chronic visceral hypersensitivity of irritable bowel syndrome.
    J Pain. 2022 Oct 15. pii: S1526-5900(22)00433.
    PubMed    
    Abstract available

  70. BENTELE M, Stengel A
    [Hypnotherapy for Irritable Bowel Syndrome].
    Psychother Psychosom Med Psychol. 2022;72.
    PubMed    
    Abstract available

  71. NASRUN NE, Fujita K, Chieda K, Abiko Y, et al
    Association between impaired healing after orthognathic surgery and irritable bowel syndrome: A case report and literature review.
    Int J Surg Case Rep. 2022;100:107745.
    PubMed    
    Abstract available

  72. SHIN SY, Park S, Moon JM, Kim K, et al
    Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.
    J Neurogastroenterol Motil. 2022;28:642-654.
    PubMed    
    Abstract available

  73. JOSEFSSON A, Tornblom H, Simren M
    Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2022;28:630-641.
    PubMed    
    Abstract available

  74. KIM JH, Lee SW, Kwon Y, Ha EK, et al
    Infantile Colic and the Subsequent Development of the Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2022;28:618-629.
    PubMed    
    Abstract available

  75. MIN YW, Rezaie A, Pimentel M
    Bile Acid and Gut Microbiota in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2022;28:549-561.
    PubMed    
    Abstract available

  76. JIANG W, Wu J, Zhu S, Xin L, et al
    The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2022;28:540-548.
    PubMed    
    Abstract available

  77. LV L, Ruan G, Ping Y, Cheng Y, et al
    Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsul
    Front Cell Infect Microbiol. 2022;12:1025889.
    PubMed    
    Abstract available

  78. KASAHARA S, Matsudaira K, Sato N, Niwa SI, et al
    Attention-Deficit/hyperactivity disorder and centralized pain: A review of the case of John F. Kennedy.
    Clin Case Rep. 2022;10:e6422.
    PubMed    
    Abstract available

  79. NOGUEIRA V, Chang CK, Lan CY, Pereira C, et al
    Causative links between ER stress and oxidative damage in a yeast model of human N88S seipinopathy.
    Free Radic Biol Med. 2022;192:165-181.
    PubMed    
    Abstract available

  80. FRISSORA CL, Rao SSC
    Sucrose intolerance in adults with common functional gastrointestinal symptoms.
    Proc (Bayl Univ Med Cent). 2022;35:790-793.
    PubMed    
    Abstract available

  81. GRANT RK, Brindle WM, Donnelly MC, McConville PM, et al
    Gastrointestinal and liver disease in patients with schizophrenia: A narrative review.
    World J Gastroenterol. 2022;28:5515-5529.
    PubMed    
    Abstract available

  82. FLORES-CALDERA I, Ramos-Echevarria PM, Oliveras-Torres JA, Santos-Pinero N, et al
    Ibero-American Endometriosis Patient Phenome: Demographics, Obstetric-Gynecologic Traits, and Symptomatology.
    Front Reprod Health. 2021;3:667345.
    PubMed    
    Abstract available

  83. MCNAMARA HC, Frawley HC, Donoghue JF, Readman E, et al
    Peripheral, Central, and Cross Sensitization in Endometriosis-Associated Pain and Comorbid Pain Syndromes.
    Front Reprod Health. 2021;3:729642.
    PubMed    
    Abstract available

  84. RASHID A
    Yonder: Primary aldosteronism, artificial intelligence, irritable bowel syndrome, and financial toxicity.
    Br J Gen Pract. 2022;72:534.
    PubMed    


  85. RHYS-JONES D, Varney JE, Muir JG, Gibson PR, et al
    Application of The FODMAP Diet in a Paediatric Setting.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  86. DICKS LMT
    How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?
    Microorganisms. 2022;10.
    PubMed    
    Abstract available

  87. SMOLINSKA S, Winiarska E, Globinska A, Jutel M, et al
    Histamine: A Mediator of Intestinal Disorders-A Review.
    Metabolites. 2022;12.
    PubMed    
    Abstract available

  88. OKAWA Y
    A Discussion of Whether Various Lifestyle Changes can Alleviate the Symptoms of Irritable Bowel Syndrome.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  89. CASTIGLIONE V, Berodes M, Lukas P, Louis E, et al
    New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  90. MAKAROVA AA, Ruchkina IN, Parfenov AI, Indeykina LK, et al
    [The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome].
    Ter Arkh. 2021;93:969-974.
    PubMed    
    Abstract available

  91. ANDREEV DN, Kucheryavyy YA
    [Obesity as a risk factor for diseases of the digestive system].
    Ter Arkh. 2021;93:954-962.
    PubMed    
    Abstract available

  92. ARDATSKAYA MD, Butorova LI, Kalashnikova MA, Nugaeva NR, et al
    [Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy].
    Ter Arkh. 2021;93:923-931.
    PubMed    
    Abstract available

  93. ANDREEV DN, Maev IV
    [Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study].
    Ter Arkh. 2021;93:897-903.
    PubMed    
    Abstract available

  94. RUCHKINA IN, Fadeeva NA
    [The role of a combined probiotic in the treatment of lactase deficiency].
    Ter Arkh. 2021;93:431-434.
    PubMed    
    Abstract available

  95. ANDREEV DN, Bordin DS, Vyuchnova ES, Lebedeva EG, et al
    [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Ter Arkh. 2022;94:1099-1108.
    PubMed    
    Abstract available

  96. AKHMEDOV VA
    [Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19].
    Ter Arkh. 2022;94:277-282.
    PubMed    
    Abstract available

  97. YAKOVENKO EP, Strokova TV, Ivanov AN, Iakovenko AV, et al
    [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
    Ter Arkh. 2022;94:180-187.
    PubMed    
    Abstract available

  98. PARFENOV AI
    [Food intolerances and the small intestine].
    Ter Arkh. 2022;94:153-159.
    PubMed    
    Abstract available

  99. BERGER M, Guiraud L, Dumas A, Sagnat D, et al
    Prenatal stress induces changes in PAR2- and M3-dependent regulation of colon primitive cells.
    Am J Physiol Gastrointest Liver Physiol. 2022.
    PubMed    
    Abstract available

  100. CHOJNACKI C, Konrad P, Kaczka A, Medrek-Sochab M, et al
    The role of serotonin in pathogenesis of unclassified irritable bowel syndrome.
    Pol Merkur Lekarski. 2022;50:277-281.
    PubMed    
    Abstract available

  101. BRAYDEN DJ
    Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials.
    BioDrugs. 2022 Oct 25. pii: 10.1007/s40259-022-00562.
    PubMed    
    Abstract available

  102. XIONG Y, Wei H, Chen C, Jiao L, et al
    Coptisine attenuates postinfectious IBS via Nrf2dependent inhibition of the NLPR3 inflammasome.
    Mol Med Rep. 2022;26.
    PubMed    
    Abstract available

  103. YOSHIOKA T, Ohashi M, Matsumoto K, Omata T, et al
    Repeated psychological stress, chronic vicarious social defeat stress, evokes irritable bowel syndrome-like symptoms in mice.
    Front Neurosci. 2022;16:993132.
    PubMed    
    Abstract available

  104. SHI YZ, Tao QF, Qin D, Chen M, et al
    Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysis.
    Front Physiol. 2022;13:1001978.
    PubMed    
    Abstract available

  105. YOU S, Ma Y, Yan B, Pei W, et al
    The promotion mechanism of prebiotics for probiotics: A review.
    Front Nutr. 2022;9:1000517.
    PubMed    
    Abstract available

  106. COSTANTINO A, Aversano GM, Lasagni G, Smania V, et al
    Diagnostic management of patients reporting symptoms after wheat ingestion.
    Front Nutr. 2022;9:1007007.
    PubMed    
    Abstract available

  107. HAMBLIN H, Gunaratne AW, Clancy A, Pilarinos D, et al
    Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience.
    Gastroenterol Res Pract. 2022;2022:6083896.
    PubMed    
    Abstract available

  108. YANAI K, Ishibashi K, Morishita Y
    MicroRNAs in Irritable Bowel Syndrome: a Systematic Review.
    Discov Med. 2022;34:7-18.
    PubMed    
    Abstract available

  109. GOLLA R, Vuyyuru S, Kante B, Kumar P, et al
    Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study.
    Clin Gastroenterol Hepatol. 2022 Oct 20. pii: S1542-3565(22)01004.
    PubMed    
    Abstract available

  110. SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
    Circulating polyunsaturated fatty acids and pain intensity in five chronic pain conditions.
    J Pain. 2022 Oct 20. pii: S1526-5900(22)00434.
    PubMed    
    Abstract available

  111. ALGERA JP, Magnusson MK, Ohman L, Storsrud S, et al
    Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Sep 29. doi: 10.1111/apt.17239.
    PubMed    
    Abstract available

  112. SHIN A
    Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2022;56:1300-1301.
    PubMed    


  113. FAIRBRASS KM, Hamlin PJ, Gracie DJ, Ford AC, et al
    Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
    Aliment Pharmacol Ther. 2022;56:1302-1303.
    PubMed    


  114. QUIGLEY EMM
    Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis?
    Aliment Pharmacol Ther. 2022;56:1497-1498.
    PubMed    


  115. BRENNER DM, Lacy BE, Ford AC, Bartolini W, et al
    Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials.
    Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00551.
    PubMed    
    Abstract available

  116. OH CJ, Rezaie A
    Small Is Big: Why the Analysis of the Fecal Microbiome Provides Little Important Information on IBS Severity.
    Dig Dis Sci. 2022;67:4974-4975.
    PubMed    


  117. CHENG F, Fan Z, Lin C, Zhu Y, et al
    Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069.
    PubMed    
    Abstract available

  118. CAMILLERI M, Dilmaghani S
    Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
    Gastroenterology. 2022;163:815-817.
    PubMed    


  119. JALANKA J, Gunn D, Singh G, Krishnasamy S, et al
    Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
    Gut. 2022 Sep 28. pii: gutjnl-2021-326828. doi: 10.1136/gutjnl-2021-326828.
    PubMed    
    Abstract available

  120. TACK J, Van den Houte K, Carbone F
    Role of the DOMINO diet application for managing IBS in primary care and beyond.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328315. doi: 10.1136/gutjnl-2022-328315.
    PubMed    


  121. PETITFILS C, Maurel S, Payros G, Hueber A, et al
    Identification of bacterial lipopeptides as key players in IBS.
    Gut. 2022 Oct 14. pii: gutjnl-2022-328084. doi: 10.1136/gutjnl-2022-328084.
    PubMed    
    Abstract available

  122. CAMILLERI M, Boeckxstaens G
    Irritable bowel syndrome: treatment based on pathophysiology and biomarkers.
    Gut. 2022 Oct 28. pii: gutjnl-2022-328515. doi: 10.1136/gutjnl-2022-328515.
    PubMed    
    Abstract available

  123. GHOSHAL UC, Sachdeva S, Ghoshal U, Misra A, et al
    Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.
    Indian J Gastroenterol. 2022 Oct 10. pii: 10.1007/s12664-022-01292.
    PubMed    
    Abstract available

  124. YAMAMOTO Y, Furukawa S, Watanabe J, Kato A, et al
    Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.
    Int J Colorectal Dis. 2022 Oct 20. pii: 10.1007/s00384-022-04267.
    PubMed    
    Abstract available

  125. WANG Y, Chen N, Niu F, Li Y, et al
    Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
    Int J Colorectal Dis. 2022 Oct 17. pii: 10.1007/s00384-022-04261.
    PubMed    
    Abstract available

  126. GIULIO M, Gaia S, Andrea C, Giacomo C, et al
    Recurrent diverticulitis after elective surgery.
    Int J Colorectal Dis. 2022;37:2149-2155.
    PubMed    
    Abstract available

  127. FRANCO L, Jones-Pauley M, Tamimi O, Neshatian L, et al
    Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and Anxiety.
    J Clin Gastroenterol. 2022 Oct 10. pii: 00004836-990000000-00068.
    PubMed    
    Abstract available

  128. HONG G, Li Y, Yang M, Li G, et al
    Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Scand J Gastroenterol. 2022 Oct 25:1-10. doi: 10.1080/00365521.2022.2136013.
    PubMed    
    Abstract available

  129. GROZIC A, Coker K, Dussik CM, Sabir MS, et al
    Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.
    PLoS One. 2022;17:e0275683.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;